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Original Article
Purpose: We sought to evaluate the safety and effectiveness of patient-specific ocular prostheses produced by three-di-
mensional (3D) printing and the sublimation technique. A comparison with prostheses produced using manual manufacturing 
methods was then performed.
Methods: To confirm the biological and physiochemical safety, cytotoxicity, systemic acute toxicity, intradermal reaction, 
and skin sensitization tests were conducted according to the International Organization for Standardization guidelines. The 
compressive strength of the prostheses was also tested. Further, a case series of three patients who wore the 3D printed 
prostheses for more than eight hours daily for 4 weeks was executed. Self-assessments by these individuals using a question-
naire and safety evaluations focusing on the occurrence of conjunctival inflammation or allergic reactions according to the 
Cornea and Contact Lens Research Unit criteria by slit-lamp examination and similarity assessment were completed. 
Results: The 3D printed ocular prostheses met the necessary qualifications per the biological and physiochemical safety tests, 
showing the absence of cytotoxicity, acute systemic toxicity, intradermal reactivity, and skin-sensitizing potency. Also, there 
was no difference in strength test results between previous ocular prostheses and the 3D printed ones. Self-assessment by 
the patients yielded satisfactory results, with no significant difference in the level of satisfaction reported for the 3D printed 
and previous handmade ocular prostheses. The 3D printed prosthesis did not trigger any side effects in the conjunctival sac 
and showed similar objective findings with respect to the color of the iris, sclera, and vessel patterns.
Conclusions: Our study confirms the biologic and physiochemical safety of 3D-printed ocular prostheses created using com-
puter-aided design technology and a sublimation technique. The patients’ questionnaires and the judgment of the ophthal-
mologists/ocularists showed that the 3D printed ocular prosthesis was acceptable in function and appearance through a case 
series report.
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Ocular prostheses are important rehabilitation tools for 
anophthalmic patients, improving their quality of life by 
restoring the symmetrical appearance of the face [1-3]. 
However, current production methods still fail to make the 
patient’s eye look natural while simultaneously ensuring 
that the area feels comfortable. Ocular prostheses can be 
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produced by ready-made stock shells or can be handmade 
[4,5]. Of these, handmade ocular prostheses garner higher 
results in satisfaction surveys because they are cus-
tom-made to fit the patient [6]. However, the success of the 
handmade technique is not only extremely dependent on 
the experience of the ocularist but is also time-consuming, 
labor-intensive, and costly to adopt [4].
Recently, the application of three-dimensional (3D) 
printing technology in the medical field is gaining atten-
tion [7]. 3D printing has been introduced in the medical 
field as a means to develop teaching aids for students, pre-
plan surgical guides for surgeons, and therapeutic tools for 
patients [7,8]. Most 3D printers produce objects by lami-
nating materials based on 3D model data by way of an ad-
ditive process [9]. With the development of 3D printing 
technology and the increase in the variety of materials that 
can be used for printing, it has become possible to create 
objects that cannot be easily manufactured by convention-
al methods. Alam et al. [10] was among the first investiga-
tors to use 3D printing to design ocular prostheses in 2017. 
The team conducted a study on the eyes of two patients 
using computer-aided design (CAD) technology that pro-
duced more comfortable prostheses in less time. However, 
3D printing technology was limited at that time to only 
being able to print the scleral form; the iris and vessels still 
required painting by hand. Until recently, no objective and 
standardized technique of manufacturing ocular prosthe-
ses using 3D printers has existed. Our research team re-
cently reported on a novel semi-automated method using 
3D printing technology and a sublimation transfer printing 
technique for manufacturing customized ocular prostheses 
[11]. In our previous study, we used a 3D printer to produce 
ocular prostheses. After printing the ocular prosthesis 
shape, the iris and blood vessels were printed onto the ocu-
lar prosthesis using a dye sublimation transfer technique.
The purpose of the present study is to evaluate the safety 
and effectiveness of patient-specific ocular prosthesis cre-
ation by 3D printer in a clinical case series of three pa-
tients. Through this study, we confirmed that 3D printing 
paired with the mentioned sublimation transfer technique 
could be substituted for traditional handmade manufactur-
ing methods of ocular prostheses. 
Materials and Methods
Ethics statement
The study was approved by the institutional review 
board of the College of Medicine, Yonsei University (1-
2019-0064). Informed consent was obtained from the in-
cluded patients and the study strictly adhered to the tenets 
of the Declaration of Helsinki.
Participants
This was a single-center, preliminary case series report. 
The major inclusion criteria included the following: age 
between 19 and 75 years, status post-enucleation or -evis-
ceration, and duration of ocular prosthesis use for at least 
one year before enrollment. The exclusion criteria included 
the following: age younger than 19 years, signs of conjunc-
tival and socket contracture or inflammation, and exposure 
or infection of the orbital implant.
3D data acquisition and 3D printing of the ocular pros-
thesis 
The process of semi-automated 3D printing of ocular 
prostheses was performed as previously described [11]. Af-
ter obtaining 3D modeling data, the scleral model was 
printed using DS131 (Carima, Seoul, Korea), a digital 
light-processing (DLP) 3D printer with biocompatible pho-
topolymer resin (FotoTec DLP.A; Dreve, Unna, Germany). 
Unlike in the previous paper [11], where, during the pro-
cess of applying color and shape to the scleral surface, the 
photo of the other normal eye was previously taken and 
transferred, in this study, a digital image of the iris and 
blood vessels of the patient’s other eye was generated using 
a color diagnostic tool and transferred onto the scleral sur-
face using a sublimation transcription technique (Fig. 1A-
1F). Subsequent contents are the same as those existing in 
our previous paper [11]. Lastly, the ocular prosthesis was 
completed by coating the surface with transparent poly-
methyl methacrylate. This technology makes it possible to 
produce personalized ocular prostheses objectively and 
consistently and has the advantage of reducing the time 
and skills required to produce ocular prostheses.
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Color diagnostic tool
We created a standard image dataset for enabling images 
to be sublimated on the sclera surface conveniently and 
quickly, even if not overseen by an expert ocularist. Stan-
dard image data were created to match the patient’s normal 
eye. The representative image of 4,000 × 4,000 pixels 
(1,500 pixels/inch) consisted of iris colors, iris patterns, 
scleral colors, vessel colors, and vessel densities based on 
the standardized dataset. The process of compiling the 
dataset of the seven iris colors and six iris patterns was 
performed as previously reported [12]. Then, we further 
developed a color diagnostics tool to apply the colors of the 
standardized dataset objectively and consistently; nine iris 
colors, six iris patterns, nine scleral colors, seven vessel 
colors and five vessel densities (Fig. 2A, 2B). The 12 × 
9-cm-sized oval-shaped tool was printed on a paper with a 
2.5-cm opening at the center. Each page was composed of 
the iris colors, iris patterns, scleral colors, vessel colors, 
and vessel densities aligned in a radiating formation sur-
rounding the center. Then, we placed an image of the nor-
mal eye in the middle of the color diagnostic tool and se-
lected the standard color or shape that most closely 
resembles it. Finally, the image data were directly printed 
on the scleral surface using the sublimation transfer tech-
nique.
Evaluation of the biological and physicochemical safety 
of the 3D ocular prosthesis
Safety was assessed using cytotoxicity, systemic acute 
toxicity, intradermal reaction, and skin sensitization tests 
according to the International Organization for Standard-
ization 10993 Series Biological Evaluation of Medical De-
vices guidelines [13]. Ten 3D-printed ocular prostheses 
were used for each test. Compressive strength testing using 








Fig. 2. Color diagnostic tool for sublimation. (A) The 12 × 9-cm-
sized oval-shaped tool was printed on a paper with a 2.5-cm open-
ing at the center to compare iris color, vessel color, scleral color 
and vessel densities. (B) The photographs below show the process 
for matching iris color and vessel color. Informed consent for pub-







Fig. 1. Process of sublimation transfer printing for three-dimen-
sional (3D) ocular prosthesis creation. (A) The ocular prosthesis 
manufacturer selects a scleral 3D modeling file with customized 
details of the patient’s conjunctiva and then manufactures the 
sclera product using a digital light-processing 3D printer. (B) 
After washing the impurities remaining on the surface of the 
sclera product with alcohol, the sclera product is completed. (C) 
The graphic data that most closely matches the image of the pa-
tient’s healthy eyes from standardized color sets are selected to 
match the iris color and pattern of the patient. (D) After printing 
the graphic data on a transfer paper with a sublimation transfer 
inkjet printer, the transfer paper is dried at room temperature. 
(E) The sclera product is placed in the center of the sublimation 
transfer machine table, the center of the transfer paper is aligned 
to the marked pupil center of the sclera, and sublimation transfer 
printing is initiated. (F) The final product of the 3D ocular pros-
thesis with sublimation transfer technique.
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MA, USA) was conducted at a constant crosshead speed 
(19.8–25.6 mm/min). 
Clinical case series of three patients
We conducted a clinical observational study involving 
three eyes of three patients who were assessed after wear-
ing 3D printed ocular prostheses according to three cate-
gories: self-assessment by questionnaire performed by the 
patient, conjunctival socket evaluation by slit-lamp imag-
ing performed by an ophthalmologist, and assessments of 
ocular similarity performed by an ocularist.
On the day of the first visit, a semi-automated 3D print-
ed ocular prosthesis was manufactured. The patients were 
asked to wear the ocular prosthesis for more than eight 
hours a day for 4 weeks. 3D printed ocular prosthesis man-
agement was conducted in a manner similar to that of the 
patients’ existing prostheses.
1) Self-assessment by questionnaire
We evaluated the patients’ satisfaction in cosmetic and 
functional aspects by questionnaire (Supplemental Table 1). 
The patients were asked to fill out the study questionnaire 
at 2 and 4 weeks. Patients were asked to give answers to 
questions on topics including the color and shape (cosmetic 
evaluation) and experiences with symptoms including the 
levels of eye crust (frequency, color, volume, and viscosi-
ty), pruritus, pain, dryness, and eyelid swelling (functional 
evaluation). 
2) Safety assessment by slit-lamp imaging
A slit-lamp examination with photography was per-
formed to grade conjunctival changes (Supplemental Table 
2). Conjunctival inf lammation and allergic reactions in 
both the lower and upper palpebral areas were evaluated 
using a grading scale (grades 0–4) according to Cornea 
and Contact Lens Research Unit standards [14]. 
3) Similarity assessment
An assessment of the similarity between the 3D printed 
ocular prosthesis and the normal eye accroding to iris col-
or, scleral color, iris pattern, and vessel pattern was per-
formed by an expert ocularist (SWB) as very similar, simi-
lar, roughly similar, different, or very different.
Results
Evaluation of the safety and strength of the 3D ocular 
prosthesis 
The 3D printed ocular prosthesis passed the biocompati-
bility standards for cytotoxicity, acute systemic toxicity, 
intradermal toxicity, and sensitization. Cell cytotoxicity in 
vitro testing using mouse-derived fibroblasts (L-929 cells) 
revealed no isolation of intracytoplasmic granules, cell ly-
sis, or the inhibition of cell growth. No case of animal 
death was observed due to acute systemic toxicity during 
in vivo testing using ICR mice and no general symptoms, 
weight changes, or specific autopsy findings related to the 
administration of the test substance were observed. In a 
Hartley guinea pig maximization in vivo test, no general 
symptoms, weight changes, or death were observed and 
the material from which the prothesis was made was 
shown to be a non-sensitizing substance of Magnusson and 
Kligman grade 0 [15]. Further, an animal intracutaneous 
(intradermal) reactivity in vivo test was conducted using 
New Zealand White rabbits and no abnormal symptoms or 
weight changes related to the administration of the test 
substance were observed and the 3D printed ocular pros-
thesis was considered to trigger no intradermal reaction 
(Table 1).
The previous handmade ocular prostheses (n = 10) had a 
mean compressive strength of 2,540 ± 381 N, while the 
3D-printed ocular prostheses (n = 10) showed a value of 
Table 1. Safety tests for the three-dimensional printed ocular prostheses
Test Standard Result
Cytotoxicity ISO 10993-5 No cytotoxicity
Acute systemic toxicity ISO 10993-11 No significant systemic toxicity
Intradermal toxicity ISO 10993-10 No significant toxicity or irritation
Sensitization ISO 10993-10 No dermal sensitization
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2,588 ± 407 N. There were no significant differences (p > 
0.05) between the two types of ocular prosthesis.
Clinical case series of three patients
Three patients (one female aged 26 years and two males 
aged 33 and 35 years) were enrolled in this study. All pa-
tients wore their 3D printed ocular prostheses daily for a 
period of 4 weeks. 
1) Self-assessment by questionnaire
Fig. 3A and 3B presents representative photos and slit-
lamp details of the three enrolled patients. Self-assess-
ments performed by patients using the questionnaire were 
conducted to evaluate cosmetic and functional outcomes 
of the 3D printed ocular prostheses. After wearing their 
prostheses for 4 weeks, the patients were “very satisfied” 
with both the color and shape as part of the cosmetic eval-
uation. Separately, the frequency, color, volume, and vis-
cosity of eye crust were assessed and, in all four catego-
ries, the survey results indicated improvements were 
observed after wearing the 3D printed ocular prostheses. 
Pruritis was not experienced by any patient after wearing 
the 3D printed ocular prostheses. Also, no newly devel-
oped pain was noted in two patients; moreover, previously 
reported existing pain disappeared after wearing the 3D 
printed ocular prosthesis in the third patient. The level of 
ocular dryness did not change in two patients and im-
proved in the third patient. After wearing the 3D printed 
ocular prostheses for 4 weeks, eyelid swelling was not ob-
served in any of the patients. During the final evaluation 
conducted 4 weeks later, patients reported improvements 
in both cosmetic and functional satisfaction levels com-
pared to their existing ocular prostheses (Supplemental Ta-
ble 3).
2) Safety assessment by slit-lamp imaging
During the safety assessment, conjunctival inflammation 
and allergic reactions were graded in accordance with the 
Cornea and Contact Lens Research Unit criteria by an 
ophthalmologist. The conjunctival inf lammation did not 
change in two patients and showed an improvement from 
grade 2 to 1 after wearing the 3D printed ocular prosthesis 
in the third patient. No instance of conjunctival allergic re-
action after 4 weeks was observed in any of the patients 
(Supplemental Table 2).
3) Similarity assessment
All three prostheses were deemed by the expert ocularist 
to show “very similar” results with regard to iris color, 
scleral color, iris pattern, and vessel patterns when com-
pared with the patients’ other (real) eyes. 
Discussion
The world’s first ocular prosthesis is believed to have 
been made by the Egyptians in that prostheses constructed 
from stone, silver, and gold were found in mummies and 
statues [1,16,17]. The usage of glass as a prosthetic material 
gradually resulted in the use of dental acrylic and methyl 
methacrylate [1]. More recently, current CAD 3D printing 
technology has been adopted to create ocular prostheses 
[10,18]. In our previous paper, we published the details of a 
novel semi-automated method that incorporated 3D print-
ing technology and a sublimation transfer printing tech-
nique to manufacture customized ocular prostheses [11]. 
Moreover, we applied a new technology—a color diagnos-
Fig. 3. Photographs of three patients’ normal eyes and anophthal-
mic eyes. (A) Gross photos of the three patients at primary gaze. 
(B) Slit-lamp photos of the normal eye, the ocular prosthesis and 
the upper and lower conjunctiva of the anophthalmic socket. The 
ocular prosthesis is marked by an asterisk. OD = right eye; OS 
= left eye; UL = upper lid; LL = lower lid. Informed consent for 
publication of the clinical images was obtained from the patients. 
A B
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tic tool—in this paper. Here, during the process of making 
the ocular prosthesis, an ocularist drew the iris after ob-
serving the patient’s normal eye with acrylic ink and used 
red silk fibers to imitate the vessels traditionally [19]. This 
stage plays an important role in satisfying the patient and 
ensures the color and pattern of the ocular prosthesis will 
be delivered appearing most similar to those of the healthy 
eye. In our previous paper, we sublimated the photograph 
of the other normal eye; however, when the photograph is 
sublimated on the surface of the prosthesis, the printed im-
age is often different from the actual ocular image, which 
is a limitation. So, we created graphic data by applying a 
color diagnostic tool, which is a simple and fast technique, 
reduces errors in the imaging color process, and has the 
advantage of requiring minimal artistic skill. There are 
several reports covering 3D printing of ocular prostheses 
[10,18,20]. To the best of our knowledge, however, this is 
the first paper to evaluate the safety and efficacy of such in 
a prospective, exploratory clinical case series.
Still, papers on the development of ocular prostheses us-
ing 3D printing technology have explored a number of as-
pects. Various authors of the published papers commonly 
performed 3D volume reconstruction using computed to-
mography, designed the data using CAD, and printed 3D 
ocular prostheses to overcome the drawbacks of the previ-
ous ocular prostheses. Ye et al. [20] printed using standard 
polymer filament and melted polylactic acid and the patient 
was reported to be satisfied with the appearance of their 
prosthesis, but the paper lacks details on the exact fol-
low-up period or other complications. Another report used 
CAD to develop a design that was hollow on the inside to 
reduce the weight of the prosthesis and printed with bio-
compatible polymethyl methacrylate. The satisfaction sur-
vey result indicated satisfaction was apparent with both 
the shape and comfort level of the ocular prosthesis [10]. 
Lastly, Ruiters et al. [18] reported the case of a 68-year-old 
male who, after 6 months of wearing a 3D-printed ocular 
prosthesis, reported no significant discomfort. However, 
this was just a single case report and was limited because 
additional efforts to find an agent that would adhere to the 
ophthalmic socket were needed. 
The difference between these existing published studies 
and our research is that, for the first time in our paper, a 
sublimation transfer technique with a color diagnostic tool 
was used to omit the process of direct painting on the 3D 
printed material. Second, to confirm that it was biological-
ly safe and to test whether the intensity was similar to that 
of the previous prosthesis, experiments certified by the In-
ternational Organization for Standardization (cytotoxicity, 
acute systemic toxicity, intradermal toxicity, sensitization 
tests) were conducted. Third, a case series was conducted 
that included three patients who performed a self-assess-
ment, received a conjunctival socket assessment performed 
by an ophthalmologist, and a similarity assessment con-
ducted by an ocularist. This series showed that there was 
no shortcoming evident as compared with customized 
manufactured products. So far, the studies focused on cre-
ating ocular prostheses with 3D printing technology have 
not focused on safety and effectiveness. Among the afore-
mentioned papers, the studies briefly asked about patient 
satisfaction with appearance or discomfort during wear-
ing, but there have been no systematic papers published on 
safety and effectiveness to date. 
When creating an agenda using the 3D printing technol-
ogy introduced in this paper, it is expected to save time 
compared to creating a conventional handmade custom-
ized ocular prosthesis. In addition, the 3D printing ap-
proach can save existing patient data and reuse it after-
ward, reducing the costs of production and making it 
easier to replace lost or produce multiple prostheses. Rela-
tively inexperienced ocularists are able to create prostheses 
easily using a semi-automatic process. In this report, we 
were able to clinically verify the validity of these advan-
tages that were discussed in our previous report [11].
In conclusion, we introduce the details of a new attempt 
to evaluate the safety and effectiveness of 3D printed ocu-
lar prostheses created using CAD and a sublimation tech-
nique. Although the number of patients was small and the 
duration of wearing the ocular prostheses was relatively 
short, the results are encouraging. Similar studies involv-
ing larger sample sizes that explore our results in more de-
tail will help to validate the benefits of this advanced tech-
nology when compared with traditional methods. Also, 
long-term research is needed for the next 3 to 5 years when 
considering the replacement period of the eye. In the near 
future, we predict the wide-spread use of 3D printed pros-
theses as part of the growth of personalized medicine will 
occur.
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Supplementary Table 1. The self-assessment questionnaire
Category Visit Grade
Cosmetic Very unsatisfied Unsatisfied Neutral Satisfied Very satisfied
Color 4 wk
Shape 4 wk


























 Eyelid swelling Present None
4 wk






Supplemental Table 2. Safety assessment results according to slit-lamp imaging 
Category Visit Patient 1 Patient 2 Patient 3
Conjunctival inflammation Initial Grade 1 Grade 2 Grade 1
4 wk Grade 1 Grade 1 Grade 1
Allergic reaction Initial Grade 1 Grade 1 Grade 1
4 wk Grade 1 Grade 1 Grade 1
Supplemental Table 3. Self-assessment questionnaire results reported by the patients
Category   Visit Patient 1 Patient 2 Patient 3
Cosmetic Color 4 wk Very satisfied Very satisfied Very satisfied
Shape 4 wk Very satisfied Very satisfied Very satisfied
Function Eye crust Frequency Initial None Constantly Daily
2 wk None Daily Daily
4 wk None Daily Daily
Color Initial Clear White Yellow
2 wk Clear White Yellow
4 wk Clear White Yellow
Volume Initial None Small Large
2 wk None Small Large
4 wk None Small Moderate
Viscosity Initial None Moderate Moderate
2 wk None Low Moderate
4 wk None Low Moderate
Pruritis Initial None None None
2 wk None None None
4 wk None None None
Pain Initial None Mild None
2 wk None Mild None
4 wk None None None
Dryness Initial None Severe Severe
2 wk None Mild Severe
4 wk None Mild Severe
Eyelid swelling 4 wk None None None
Final evaluation Cosmetic satisfaction 4 wk Very satisfied Very satisfied Very satisfied
Functional satisfaction 4 wk Very satisfied Very satisfied Very satisfied
